IDEMMED
ActiveIDEMMED has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €332k and a net result of €38k. Equity is growing by ~11.2% per year across the filed fiscal years. Its solvency ranks better than 48% of 19909 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
96
/ 100
Excellent▲ +44 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability57▲+57
Solvency100=
Growth78▲+26
Stability100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 3.75 against 3.98 in 2023), and 34.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 17-09-2025, 48 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
48 d late
2023
86 d late
2022
84 d late
2021
95 d late
2019
34 d late
2018
400 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€332k▲ 13.0%
2023 · €294k
2018: €129k
2019: €165k
2021: €307k
2022: €342k
2023: €294k
2018 → 2024
Total assets
€508k▼ 7.5%
2023 · €549k
2018: €274k
2019: €354k
2021: €451k
2022: €454k
2023: €549k
2018 → 2024
Net result
€38k
2023 · €-49k
2018: €10k
2019: €35k
2021: €90k
2022: €36k
2023: €-49k
2018 → 2024
Working capital
€186k▼ 7.8%
2023 · €201k
2018: €-63k
2019: €46k
2021: €173k
2022: €192k
2023: €201k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20192021202220232024Trend
Equity€165k-€307k▲ 86.4%€342k▲ 11.6%€294k▼ 14.3%€332k▲ 13.0%
Operating result€60k-€140k▲ 133%€85k▼ 39.0%€-51k€169k
Net result€35k-€90k▲ 156%€36k▼ 60.6%€-49k€38k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2024: €169k after a loss of €51k in 2023, the highest year so far.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €508k
Fixed assets
€255k▼ 9.0%
Current assets
€253k▼ 5.9%
Equity and liabilities €508k
Equity
€332k▲ 13.0%
Provisions
€83k▼ 42.6%
Debt
€93k▼ 15.7%
The debt ratio falls from 20.1% to 18.3%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€200k▲
2023 · €-20k
Cash flow
€69k▲
2023 · €-18k
Solvency
65.3%▲
2023 · 53.5%
Current ratio
3.75▼
2023 · 3.98
Quick ratio
3.75▼
2023 · 3.98
Debt / equity
0.28▼
2023 · 0.38
ROE
11.5%▲
2023 · -16.6%
ROA
7.5%▲
2023 · -8.9%
Interest coverage
1.53▲
2023 · -7.71
Debt
€93k▼
2023 · €110k
Debt ≤ 1 year
€67k▼
2023 · €68k
Debt > 1 year
€25k▼
2023 · €42k
Income taxes
€134▲
2023 · €-4k
Staff costs
€46k▲
2023 · €40k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€549k€508k▼
Fixed assets21/28€280k€255k▼
Intangible fixed assets21-€0
Tangible fixed assets22/27€279k€254k▼
Land and buildings22€215k€201k▼
Plant, machinery and equipment23€18k€20k▲
Furniture and vehicles24€46k€33k▼
Financial fixed assets28€1k€1k=
Current assets29/58€269k€253k▼
Amounts receivable within one year40/41€99k€62k▼
Other amounts receivable41€99k€62k▼
Cash at bank and in hand54/58€167k€191k▲
Deferred charges and accrued income490/1€3k-
Equity and liabilities
Total equity and liabilities10/49€549k€508k▼
Equity10/15€294k€332k▲
Contributions10/11€6k€6k=
Reserves13€107k€107k=
Non-distributable reserves130/1€620€620=
Reserves not available under the articles1311€620€620=
Distributable reserves133€106k€106k=
Profit (loss) carried forward14€181k€219k▲
Provisions and deferred taxes16€145k€83k▼
Provisions for liabilities and charges160/5€145k€83k▼
Other liabilities and charges164/5€145k€83k▼
Amounts payable17/49€110k€93k▼
Amounts payable after more than one year17€42k€25k▼
Financial debts170/4€42k€25k▼
Amounts payable within one year42/48€68k€67k▼
Current portion of amounts payable after more than one year42€27k€67k▲
Trade debts44€35k-
Suppliers440/4€35k-
Taxes, remuneration and social security45€6k-
Remuneration and social security454/9€6k-
Income statement
Code20232024
Remuneration, social security and pensions62€40k€46k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€31k€31k▲
Provisions for liabilities and charges: additions (uses and reversals)635/8€145k€-62k▼
Other operating charges640/8€17k€17k▲
Gross operating margin9900€182k€201k▲
Operating profit (loss)9901€-51k€169k▲
Financial charges65/66B€3k€131k▲
Recurring financial charges65€3k€131k▲
Profit (loss) for the period before taxes9903€-53k€38k▲
Income taxes67/77€-4k€134▲
Profit (loss) for the period9904€-49k€38k▲
Profit (loss) for the period to be appropriated9905€-49k€38k▲
Appropriation of the result
Profit (loss) to be appropriated9906€181k€219k▲
Profit (loss) brought forward from the previous period14P€230k€181k▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
17-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 48 days late
2024
31-12
Financial
Back to profitnet €38k
Net result €38k after one loss-making year.
25-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 86 days late
2023
31-12
Financial
Weakest financial yearnet €-49k ▼237%
Net result drops to €-49k, the lowest in the series; recovery starts the following year.
23-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 84 days late
2022
03-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 95 days late
2021
31-12
Financial
Highest result since 2018net €90k ▲156%
Net result €90k, the highest in the series.
31-12
Financial
Liquidity doublescurrent ratio 3.15
Current ratio from 1.54 to 3.15; short-term debt falls from €84k to €80k.
31-12
Financial
Equity above €200kEq €307k ▲86.4%
3 profitable years in a row build equity to €307k.
2020
03-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 34 days late
03-09
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 400 days late
2019
31-12
Financial
Liquidity times 5current ratio 1.54
Current ratio from 0.29 to 1.54; short-term debt falls from €88k to €84k.
31-12
Financial
Equity above €150kEq €165k ▲27.2%
2 profitable years in a row build equity to €165k.
2018
20-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 20 days late
2017
27-09
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 58 days late
2016
26-10
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 87 days late
2015
29-09
NBB filing
Annual accounts filed
fiscal year 2014 · full schema · 60 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Chapelle-lez-Herlaimont · 2 establishment units since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue du Chêne 967160 Chapelle-lez-HerlaimontGround area
1,284 m²
Building footprint
159 m²
Volume, LiDAR
1,140 m³
2 parcels, Wallonia · tallest building 9.1 m, ±3 floors. Linked by address, not a title deed.
2 establishment units
IDEMMED
since 20042.266.283.848
IDEMMED
since 20162.266.283.947
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52010A0112/00S002 | Wallonia | 1,021 m² | 1 · 110 m² | 9.1 m · 2 fl. |
| 52010A0122/00D000 | Wallonia | 264 m² | 1 · 50 m² | 9.0 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
25490086SVIHUNUQOS43
Similar companies · same sector, comparable size
NALIALI
BE 0474.392.356
Anderlecht · Eq €332k
JORQUERA SEBASTIAN
BE 0727.609.272
Waterloo · Eq €332k
DOKTER DENIS GIELEN
BE 0881.859.761
Leopoldsburg · Eq €332k
Professeur Elie Cogan
BE 0678.941.206
Ukkel · Eq €332k
DR. MICHIEL GERITS
BE 0662.464.171
Riemst · Eq €331k
Of 9,103 companies in sector 86210 we hold annual accounts for 6,324. 5,167 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-07-2004
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:pol.popadinec@gmail.com